Literature DB >> 6251539

Use of backscattered electron imaging to quantify the distribution of inhaled crystalline silica.

A R Brody, M W Roe, J N Evans, G S Davis.   

Abstract

Inhalation of crystalline silica causes fibrotic pulmonary disease. The lung pathology of silicosis is well characterized and predictable, but the initial patterns of particle deposition and translocation are unknown. Scanning electron microscopy and backscattered electron imaging were utilized to quantify silica particle distribution in the distal air spaces of rats following a three-hour exposure to silica dust at a concentration of 100mg/m3. Lungs were perfused through the vasculature with 2% Karnovsky's fixative at a pressure of 15cm of water for 30 minutes. Blocks of tissue were dissected from five predetermined regions of the left lung and critical point dried. Mounted blocks were further dissected to reveal terminal bronchioles and their attached alveolar ducts. The tissue was sputter-coated with gold. Silica particles were visualized on the alveolar duct surfaces, then counted using negative backscattered electron imaging. The precise area of alveolar duct surfaces was calculated by using a standard magnification of 10,000X and a grid of 64cm2 over the viewing cathode ray tube. Thus, quantitation of silica particles could be expressed as number of particles per square micron. Our data show that there were fewer particles on the alveolar duct surfaces and in alveolar spaces of animals 8 hours after exposure when compared with animals 3 hours post-exposure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251539

Source DB:  PubMed          Journal:  Scan Electron Microsc        ISSN: 0586-5581


  2 in total

Review 1.  Pathogenesis of silicosis: current concepts and hypotheses.

Authors:  G S Davis
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Inhaled particles in human disease and animal models: use of electron beam instrumentation.

Authors:  A R Brody
Journal:  Environ Health Perspect       Date:  1984-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.